Related content

Cytotoxic triplets plus a biologic: state-of-the-art in maximizing the potential of up-front medical treatment of metastatic colorectal cancer

By Loupakis Fotios   Cremolini Chiara   Schirripa Marta   Masi Gianluca   Falcone Alfredo  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 4, 2011-04 ,pp. : 519-531

Informa Healthcare

Access to resources Recommend Favorite

Bevacizumab in the treatment of colorectal cancer

By Mulcahy Mary F   Benson III Al B  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 7, 2005-07 ,pp. : 997-1005

Informa Healthcare

Access to resources Recommend Favorite

Cetuximab in the treatment of patients with colorectal cancer

By Garrett Christopher R   Eng Cathy  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 7, 2011-07 ,pp. : 937-949

Informa Healthcare

Access to resources Recommend Favorite

Intensive chemotherapy of metastatic colorectal cancer: weighing between safety and clinical efficacy

By Bruera Gemma   Ricevuto Enrico  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 6, 2011-06 ,pp. : 821-824

Informa Healthcare

Access to resources Recommend Favorite

Antiangiogenesis therapy in second line metastatic colorectal cancer: similar but different

By Saif Muhammad Wasif  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 11, 2013-11 ,pp. : 1489-1493

Informa Healthcare

Access to resources Recommend Favorite